C. Salomé et al. / Tetrahedron Letters 53 (2012) 1033–1035
1035
R
HN
O
Pd(OAc)2, XantPhos,
Cs2CO3,
Cl
N
Cl
O
N
Cl
N
N
O
Cl
N
dioxane 100 °C,
HBr/AcOH
N
R = Cbz
80%
O
Fmoc-NHCH2C(O)NHMe
or
Cl
Cbz-NHCH2C(O)NHMe
Cl
13
Cl
18
17a R = Fmoc (35%)
17b R = Cbz (30%)
Cbz
HN
Pd(OAc)2, XantPhos,
Cs2CO3,
dioxane 100 °C,
O
N
Cl
N
O
N
N
N
O
N
N
Cl
N
Cl
N
Cbz-NHCH2C(O)NHMe
O
72%
Cl
20
21
19
Scheme 5. Buchwald reaction with N0-Protected-N-methyl glycinamide onto 2,6-dichloro-3-benzoylpyridine 13 and 3,6-dichloro-4-benzoylpyridazine 20 yielding the
diazepin-2-ones 18 and 19, respectively.
not work. These last conditions provided very complex mixtures.
However these results are in good agreement with data and re-
marks of Buchwald when he developed palladium catalyzed amida-
tion reactions with fairly reactive non-cyclic secondary amides.12
However, after easy N-deprotection (HBr for Cbz13 and piperi-
dine for Fmoc), the cyclization step afforded the novel functional-
ized pyridodiazepin-2-one 18 (80%). In a similar manner, the
pyridazinodiazepin-2-one 19 could be prepared in satisfactory
overall yield (72%). In this case, the diazepin-2-one ring spontane-
ously cyclized during the Buchwald reaction. It resulted from the
highly electrophilic character of the benzoyl carbonyl in 21 facili-
tating the Cbz deprotection.
Supplementary data
Supplementary data associated with this article can be found, in
References and notes
1. Boruah, R. C.; Sandhu, J. S. J. Heterocycl. Chem. 1988, 25, 459.
2. Stempel, A.; Landgraf, F. W. J. Org. Chem. 1962, 27, 4675.
3. Bolli, M. H.; Marfurt, J.; Grisostomi, C.; Boss, C.; Binkert, C.; Hess, P.; Treiber, A.;
Thorin, E.; Morrison, K.; Buchmann, S.; Bur, D.; Ramuz, H.; Clozel, M.; Fischli,
W.; Weller, T. J. Med. Chem. 2004, 47, 2776.
4. DCC, N,N0-Dicyclohexylcarbodiimide; EDCI, N-(3-Dimethylaminopropyl)-N0-
ethylcarbodiimide hydrochloride HATU, O-(7-Azabenzotriazol-1-yl)-N,N,N0,N0-
tetramethyluronium hexafluorophosphate; HBTU, O-(benzotriazol-1-yl)-
In conclusion, an alternative and original approach leading to
1,4-benzodiazepin-2-ones and two novel functionalized heterocy-
clic systems, difficult to obtain using the literature known meth-
ods, has been stepped up via a Buchwald reaction. The key step
N,N,N0,N0-tetramethyluronium
(trifluoromethyl)benzotriazolyl] oxalate.
hexafluorophosphate;
BTBO,
1,10-Bis[6-
5. Yin, J.; Buchwald, S. L. J. Am. Chem. Soc. 2002, 124, 6043.
6. Bourguignon, J.-J.; Lagouge, Y.; Lugnier, C.; Klotz, E.; Macher, J.-P.; Raboisson, P.;
Schultz, D. WO patent 098865, 2002.
needs the use of secondary amide of glycine (or other chiral a-ami-
7. Salomé, C.; Schmitt, M.; Bourguignon, J.-J. Tetrahedron Lett. 2009, 50, 3798.
no acids) allowing easy cyclocondensation step to provide the ex-
pected bi-cyclic systems (compds 12, 18, 19). Numerous
pharmacologically active 1,4-benzodiazepin-2-ones are N-substi-
tuted. However, in the specific case of a NH-free derivative would
have to be synthesized, the N-benzyl carboxamide of glycine could
be introduced and removed at the final step. The limiting rate of
this approach still remains as the moderate yields that were previ-
ously observed by Buchwald with acyclic secondary amides onto
regular aromatics4 and by us onto heteroaromatics.6 The study of
the optimization of the Pd-catalyzed reaction with other catalysts
and other ligands are ongoing to increase the yield of this key step.
Allover, this method is straightforward and might be applied to a
wide range of electron poor systems. Such functionalized bicyclic
scaffolds have not been previously described. Their biological
activities are currently under investigation.
8. In
a flame-dried Schlenk tube, palladium acetate (0.017 mmol, 0.1 equiv),
Xantphos (0.035 mmol, 0.1 equiv) and Cs2CO3 (0.530 mmol, 1.5 equiv) were
introduced under Argon. The Schlenk tube was purged few minutes with
Argon. A solution of benzophenone (0.350 mmol, 1 equiv) and the glycinamide
(0.420 mmol, 1.2 equiv) in dioxane (1 mL) was added. The mixture was stirred
at 100 °C (16 h). The solution was filtered through a pad of celite. The pad was
washed with CH2Cl2. The organic layers were combined and the solvents were
evaporated. The residue was purified by silica gel column chromatography
(cyclohexane/EtOAc) to obtain the coupled compound.
9. Radinov, R.; Chanev, J. C.; Haimova, M. J. Org. Chem. 1991, 56, 4793.
10. Hicks, Jacqueline D.; Hyde, Alan M.; Cuezva, Alberto Martinez; Buchwald,
Stephen L. J. Am. Chem. Soc. 2009, 131, 16720.
11. Fors, B. P.; Krattiger, P.; Strieter, E.; Buchwald, S. L. Org. Lett. 2008, 10, 3505;
Dooleweerdt, K.; Fors, B. P.; Buchwald, S. L. Org. Lett. 2010, 12, 2350.
12. Yin, J.; Buchwald, S. L. Org. Lett. 2000, 2, 1101.
13. An HBr solution in acetic acid (30%, 600
acid solution of benzylcarbamate derivatives (0.5 mmol). The solution was
stirred at room temperature (5 h). The volatiles were evaporated and
lL) was added dropwise to an acetic
a
saturated aqueous Na2CO3 solution was added. The aqueous layer was
extracted with CH2Cl2 (3 ꢀ 10 mL). The organic layers were combined, dried
(MgSO4), and concentrated under vacuum. The residue was purified by silica
gel column chromatography (cyclohexane/EtOAc) to obtain diazepin-2-one
derivatives 18.
Acknowledgment
Financial support from Neuro3D is gratefully acknowledged.